Equities

Hypera SA

Hypera SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (BRL)27.15
  • Today's Change-1.63 / -5.66%
  • Shares traded4.90m
  • 1 Year change-24.18%
  • Beta0.8462
Data delayed at least 15 minutes, as of Apr 25 2024 23:45 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • HYPE3:SAO price reached a new 52-week low of 27.40 at 17:11 BST
  • HYPE3:SAO price moved over +1.02% to 28.64

Key statistics

Hypera SA (HYPE3:SAO) set a new 52-week low during Thursday's trading session when it reached 27.11. Over this period, the share price is down -27.11%.
52-week range
Today
27.11Apr 25 202446.84Jul 05 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open28.79
High28.98
Low27.11
Bid27.11
Offer28.00
Previous close28.78
Average volume4.09m
Shares outstanding633.42m
Free float371.20m
P/E (TTM)10.51
Market cap17.25bn BRL
EPS (TTM)2.58
BRL
Annual div (ADY)--
Annual div yield (ADY)--
Div ex-dateApr 20 2017
Div pay-dateMay 02 2017
Data delayed at least 15 minutes, as of Apr 25 2024 23:45 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.